Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and Lymphoma

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, SW; Jeong, JM; Kang, KW; Kim, JH; Kim, TY; Lee, DS; Lee, HY; Lee, JS; Lee, YS1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Lymphoma

ArticleYear
Whole-body distribution and radiation dosimetry of (68)Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging.
    Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:1

    Topics: Adult; Aged; Female; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiation Dosage; Radiometry; Radiopharmaceuticals; Tissue Distribution

2012